Abiopharma

🔍 EDWARDS JEFFREY L (Director)

Company: BIO-RAD LABORATORIES, INC. (BIO BIO.B)

Report Date: 2026-04-21

Detailed Transactions and Holdings:

• Acquired 407 shares of Bio-Rad A Common Stock (Direct)
  Date: 2026-04-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 715.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 369 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-21 | Code: A | equity_swap_involved: 0 | shares_owned_after: 369.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Sold 407 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-21 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
• F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
• F3: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.